PAMELOR

Product NDC: 0406-9912
11-digit product format: 004069912
Labeler code: 0406
Product ID: 0406-9912_0c3b20b3-e852-4959-815a-90ed989a30e1
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: nortriptyline hydrochloride
Dosage form: CAPSULE
Route: ORAL
Labeler: SpecGx LLC
Application: NDA018013
Marketing category: NDA
Marketing start: 1977-08-01
Marketing end: 2027-11-30
Substance: NORTRIPTYLINE HYDROCHLORIDE
Active strength: 50 mg/1
Pharmacologic classes: Tricyclic Antidepressant [EPC]
NDC exclude flag: No
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS
N018013-001	PAMELOR	NORTRIPTYLINE HYDROCHLORIDE	EQ 10MG BASE	CAPSULE / ORAL	RLD, Approved before 1982
N018013-002	PAMELOR	NORTRIPTYLINE HYDROCHLORIDE	EQ 25MG BASE	CAPSULE / ORAL	RLD, Approved before 1982
N018013-003	PAMELOR	NORTRIPTYLINE HYDROCHLORIDE	EQ 75MG BASE	CAPSULE / ORAL	RLD, Approved before 1982
N018013-004	PAMELOR	NORTRIPTYLINE HYDROCHLORIDE	EQ 50MG BASE	CAPSULE / ORAL	RLD, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 176 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Source SHA-256
2026-10-15 13:18:30	2026-09	N018013-001	PAMELOR	EQ 10MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018013-002	PAMELOR	EQ 25MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018013-003	PAMELOR	EQ 75MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018013-004	PAMELOR	EQ 50MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N018013-001	PAMELOR	EQ 10MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018013-002	PAMELOR	EQ 25MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018013-003	PAMELOR	EQ 75MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018013-004	PAMELOR	EQ 50MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N018013-001	PAMELOR	EQ 10MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018013-002	PAMELOR	EQ 25MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018013-003	PAMELOR	EQ 75MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018013-004	PAMELOR	EQ 50MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018013-001	PAMELOR	EQ 10MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018013-002	PAMELOR	EQ 25MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018013-003	PAMELOR	EQ 75MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018013-004	PAMELOR	EQ 50MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018013-001	PAMELOR	EQ 10MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018013-002	PAMELOR	EQ 25MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018013-003	PAMELOR	EQ 75MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018013-004	PAMELOR	EQ 50MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018013-001	PAMELOR	EQ 10MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018013-002	PAMELOR	EQ 25MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018013-003	PAMELOR	EQ 75MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018013-004	PAMELOR	EQ 50MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018013-001	PAMELOR	EQ 10MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018013-002	PAMELOR	EQ 25MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018013-003	PAMELOR	EQ 75MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018013-004	PAMELOR	EQ 50MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018013-001	PAMELOR	EQ 10MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018013-002	PAMELOR	EQ 25MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018013-003	PAMELOR	EQ 75MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018013-004	PAMELOR	EQ 50MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018013-001	PAMELOR	EQ 10MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018013-002	PAMELOR	EQ 25MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018013-003	PAMELOR	EQ 75MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018013-004	PAMELOR	EQ 50MG BASE	CAPSULE / ORAL		RLD, Approved before 1982	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018013-001	PAMELOR	EQ 10MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018013-002	PAMELOR	EQ 25MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018013-003	PAMELOR	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS, Approved before 1982	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018013-004	PAMELOR	EQ 50MG BASE	CAPSULE / ORAL	AB	RLD, Approved before 1982	`2680178bc6a6…`

Observed Orange Book normalized TE history#

Normalized TE history page 2 of 4 · 136 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-04-04 05:41 UTC	2022-04	N018013-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N018013-002	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N018013-003	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N018013-004	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018013-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018013-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018013-003	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018013-004	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N018013-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N018013-002	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N018013-003	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N018013-004	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N018013-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N018013-002	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N018013-003	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N018013-004	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018013-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018013-002	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018013-003	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018013-004	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N018013-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N018013-002	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N018013-003	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N018013-004	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N018013-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N018013-002	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N018013-003	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N018013-004	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N018013-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N018013-002	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N018013-003	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N018013-004	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N018013-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N018013-002	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N018013-003	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N018013-004	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N018013-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N018013-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N018013-003	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N018013-004	AB	1	`b00525d2431f…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: PAMELOR

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
NORTRIPTYLINE HYDROCHLORIDE	50 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
00FN6IH15D	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 8 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
198045	Internal RxNorm lookup
198046	Internal RxNorm lookup
198047	Internal RxNorm lookup
209329	Internal RxNorm lookup
209339	Internal RxNorm lookup
209350	Internal RxNorm lookup
209391	Internal RxNorm lookup
317136	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
e17dc299-f52d-414d-ab6e-e809bd6f8acb	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
de76de11-1019-6138-2d8a-16fa566ae22a	Product name	2	20241009
53e88688-54e1-9681-22b8-e499bd715088	Product name	2	20210729

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0406-9912-03	PAMELOR	30 in 1 BOTTLE	CAPSULE	30		24

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0406-9912-03	EA - Each	0406-9912	c9e06482-c671-436c-a627-0a564132ddad	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
NORTRIPTYLINE HYDROCHLORIDE	ACTIVE INGREDIENT	00FN6IH15D	PAMELOR (NORTRIPTYLINE HYDROCHLORIDE) CAPSULE [MALLINCKRODT, INC.]	14
NORTRIPTYLINE	ACTIVE MOIETY	BL03SY4LXB	PAMELOR (NORTRIPTYLINE HYDROCHLORIDE) CAPSULE [MALLINCKRODT, INC.]	14
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	PAMELOR (NORTRIPTYLINE HYDROCHLORIDE) CAPSULE [MALLINCKRODT, INC.]	14
DIMETHICONE 350	INACTIVE INGREDIENT	2Y53S6ATLU	PAMELOR (NORTRIPTYLINE HYDROCHLORIDE) CAPSULE [MALLINCKRODT, INC.]	14
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	PAMELOR (NORTRIPTYLINE HYDROCHLORIDE) CAPSULE [MALLINCKRODT, INC.]	14
GELATIN	INACTIVE INGREDIENT	2G86QN327L	PAMELOR (NORTRIPTYLINE HYDROCHLORIDE) CAPSULE [MALLINCKRODT, INC.]	14
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	PAMELOR (NORTRIPTYLINE HYDROCHLORIDE) CAPSULE [MALLINCKRODT, INC.]	14
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PAMELOR (NORTRIPTYLINE HYDROCHLORIDE) CAPSULE [MALLINCKRODT, INC.]	14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0406-9912	PAMELOR (NORTRIPTYLINE HYDROCHLORIDE) CAPSULE [SPECGX LLC]	23	Current NDC, Legacy NDC, 1 package rows	20241208_e17dc299-f52d-414d-ab6e-e809bd6f8acb.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
PAMELOR	NORTRIPTYLINE HYDROCHLORIDE	SpecGx LLC	e17dc299-f52d-414d-ab6e-e809bd6f8acb	2024-12-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 018013 application number: NDA018013 ndc (product): 0406-9912

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
00FN6IH15D	NORTRIPTYLINE HYDROCHLORIDE	894-71-3	NORTRIPTYLINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
198045	nortriptyline HCl 10 MG Oral Capsule	PSN	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
317136	nortriptyline HCl 25 MG Oral Capsule	PSN	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
198046	nortriptyline HCl 50 MG Oral Capsule	PSN	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
198047	nortriptyline HCl 75 MG Oral Capsule	PSN	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209329	Pamelor 10 MG Oral Capsule	PSN	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209339	Pamelor 25 MG Oral Capsule	PSN	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209350	Pamelor 50 MG Oral Capsule	PSN	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209391	Pamelor 75 MG Oral Capsule	PSN	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209329	nortriptyline 10 MG Oral Capsule [Pamelor]	SBD	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209339	nortriptyline 25 MG Oral Capsule [Pamelor]	SBD	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209350	nortriptyline 50 MG Oral Capsule [Pamelor]	SBD	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209391	nortriptyline 75 MG Oral Capsule [Pamelor]	SBD	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
198045	nortriptyline 10 MG Oral Capsule	SCD	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
317136	nortriptyline 25 MG Oral Capsule	SCD	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
198046	nortriptyline 50 MG Oral Capsule	SCD	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
198047	nortriptyline 75 MG Oral Capsule	SCD	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
198045	nortriptyline (as nortriptyline HCl) 10 MG Oral Capsule	SY	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
317136	nortriptyline (as nortriptyline HCl) 25 MG Oral Capsule	SY	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
198046	nortriptyline (as nortriptyline HCl) 50 MG Oral Capsule	SY	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
198047	nortriptyline (as nortriptyline HCl) 75 MG Oral Capsule	SY	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209329	Pamelor (nortriptyline hydrochloride) 10 MG Oral Capsule	SY	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209339	Pamelor (nortriptyline hydrochloride) 25 MG Oral Capsule	SY	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209350	Pamelor (nortriptyline hydrochloride) 50 MG Oral Capsule	SY	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209391	Pamelor (nortriptyline hydrochloride) 75 MG Oral Capsule	SY	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209329	Pamelor 10 MG Oral Capsule	SY	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209339	Pamelor 25 MG Oral Capsule	SY	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209350	Pamelor 50 MG Oral Capsule	SY	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24
209391	Pamelor 75 MG Oral Capsule	SY	e17dc299-f52d-414d-ab6e-e809bd6f8acb	24

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0406-9912-03	00406991203	30 CAPSULE in 1 BOTTLE (0406-9912-03)	30 capsule	1977-08-01	2027-11-30	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Pamelor ™ (nortriptyline HCl) capsules USP Rx only	SpecGx LLC \| Patheon Inc.	2024-12-04	HUMAN PRESCRIPTION DRUG LABEL	24